{"transactions":[{"id":847445,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2026-03-12T20:05:10.000Z","date":"2026-03-12","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":1.625,"value":24375.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.61 to $1.63, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote 1."}],"balance_after":255516,"source":{"system":"sec-edgar","filing":"0001193125-26-104106","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000119312526104106/ownership.xml","form_type":"4"}},{"id":857022,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-07T00:51:00.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":3250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the options shall vest on March 5, 2027, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment."}],"balance_after":3250000,"derivative":{"exercise_price":1.84,"expiration_date":"2036-03-05","underlying":"Common Shares","underlying_shares":3250000},"source":{"system":"sec-edgar","filing":"0001193125-26-097185","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000119312526097185/ownership.xml","form_type":"4"}},{"id":906260,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-02-14T00:30:06.000Z","date":"2026-02-11","kind":"exercise","planned":false,"acquired":false,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Reporting Person was granted 124,997 RSUs on February 11, 2022, that vested with respect to approximately 25% of the shares subject to the award on each of February 11, 2023, 2024, 2025 and 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Reporting Person was granted 124,997 RSUs on February 11, 2022, that vested with respect to approximately 25% of the shares subject to the award on each of February 11, 2023, 2024, 2025 and 2026."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001193125-26-052021","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000119312526052021/ownership.xml","form_type":"4"}},{"id":906259,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2026-02-14T00:30:06.000Z","date":"2026-02-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":12869,"price":1.8,"value":23164.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 31,250 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date hereof or shares that may be acquired upon the exercise of certain stock options."}],"balance_after":240516,"source":{"system":"sec-edgar","filing":"0001193125-26-052021","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000119312526052021/ownership.xml","form_type":"4"}},{"id":906258,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2026-02-14T00:30:06.000Z","date":"2026-02-11","kind":"exercise","planned":false,"acquired":true,"shares":31250,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on February 11, 2022. RSUs convert into common shares on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on February 11, 2022. RSUs convert into common shares on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date hereof or shares that may be acquired upon the exercise of certain stock options."}],"balance_after":253385,"source":{"system":"sec-edgar","filing":"0001193125-26-052021","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000119312526052021/ownership.xml","form_type":"4"}},{"id":962595,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2025-12-20T02:55:05.000Z","date":"2025-12-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":334,"price":1.68,"value":561.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 8,925 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in the issuer's common shares that have not vested as of the date hereof nor common shares that may be acquired upon the exercise of certain stock options outstanding as of the date hereof."}],"balance_after":222135,"source":{"system":"sec-edgar","filing":"0001193125-25-327280","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000119312525327280/ownership.xml","form_type":"4"}},{"id":962594,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2025-12-20T02:55:05.000Z","date":"2025-12-19","kind":"grant","planned":false,"acquired":true,"shares":8925,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares earned by the Reporting Person upon the vesting of a portion of restricted stock units (\"RSUs\") granted to the Reporting Person on February 11, 2022 the vesting of which was subject to the achievement of certain performance conditions. RSUs are settled in common shares on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares earned by the Reporting Person upon the vesting of a portion of restricted stock units (\"RSUs\") granted to the Reporting Person on February 11, 2022 the vesting of which was subject to the achievement of certain performance conditions. RSUs are settled in common shares on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in the issuer's common shares that have not vested as of the date hereof nor common shares that may be acquired upon the exercise of certain stock options outstanding as of the date hereof."}],"balance_after":222469,"source":{"system":"sec-edgar","filing":"0001193125-25-327280","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000119312525327280/ownership.xml","form_type":"4"}},{"id":1210866,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-03-12T21:30:54.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":2300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the options shall vest on March 10, 2026, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment."}],"balance_after":2300000,"derivative":{"exercise_price":0.53,"expiration_date":"2035-03-10","underlying":"Common Shares","underlying_shares":2300000},"source":{"system":"sec-edgar","filing":"0000950170-25-038117","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000095017025038117/ownership.xml","form_type":"4"}},{"id":1272556,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2025-02-12T21:30:06.000Z","date":"2025-02-11","kind":"exercise","planned":false,"acquired":false,"shares":31249,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Reporting Person was granted 124,997 RSUs on February 11, 2022, that vested or will vest (subject to continuous service) with respect to approximately 25% of the shares subject to the award on each of February 11, 2023, 2024, 2025 and 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Reporting Person was granted 124,997 RSUs on February 11, 2022, that vested or will vest (subject to continuous service) with respect to approximately 25% of the shares subject to the award on each of February 11, 2023, 2024, 2025 and 2026."}],"balance_after":31250,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":31249},"source":{"system":"sec-edgar","filing":"0000950170-25-018887","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000095017025018887/ownership.xml","form_type":"4"}},{"id":1272555,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2025-02-12T21:30:06.000Z","date":"2025-02-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":12547,"price":0.65,"value":8155.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 31,249 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date hereof or shares that may be acquired upon the exercise of certain stock options."}],"balance_after":213544,"source":{"system":"sec-edgar","filing":"0000950170-25-018887","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000095017025018887/ownership.xml","form_type":"4"}},{"id":1272554,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2025-02-12T21:30:06.000Z","date":"2025-02-11","kind":"exercise","planned":false,"acquired":true,"shares":31249,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on February 11, 2022. RSUs convert into common shares on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on February 11, 2022. RSUs convert into common shares on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date hereof or shares that may be acquired upon the exercise of certain stock options."}],"balance_after":226091,"source":{"system":"sec-edgar","filing":"0000950170-25-018887","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000095017025018887/ownership.xml","form_type":"4"}},{"id":1355089,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2024-11-22T14:00:04.000Z","date":"2024-11-21","kind":"purchase","planned":false,"acquired":true,"shares":40000,"price":0.6,"value":24000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6046 to $0.6071, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote 1."}],"balance_after":194842,"source":{"system":"sec-edgar","filing":"0000950170-24-129972","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000095017024129972/ownership.xml","form_type":"4"}},{"id":1501056,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2024-05-28T13:11:23.000Z","date":"2024-05-24","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.05,"value":10500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average. The shares were purchased in multiple transactions at prices ranging from not less than $1.05 to not more than $1.06. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range."}],"balance_after":154842,"source":{"system":"sec-edgar","filing":"0000950170-24-064896","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000095017024064896/ownership.xml","form_type":"4"}},{"id":1587956,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-03-08T21:05:31.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":1900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the options shall vest on March 7, 2025, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment."}],"balance_after":1900000,"derivative":{"exercise_price":1.13,"expiration_date":"2034-03-07","underlying":"Common Shares","underlying_shares":1900000},"source":{"system":"sec-edgar","filing":"0001493152-24-009382","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315224009382/ownership.xml","form_type":"4"}},{"id":1650325,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2024-02-13T02:27:33.000Z","date":"2024-02-11","kind":"exercise","planned":false,"acquired":false,"shares":31249,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Reporting Person was granted 124,997 RSUs on February 11, 2022, that vested or will vest (subject to continuous service) with respect to approximately 25% of the shares subject to the award on each of February 11, 2023, 2024, 2025 and 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Reporting Person was granted 124,997 RSUs on February 11, 2022, that vested or will vest (subject to continuous service) with respect to approximately 25% of the shares subject to the award on each of February 11, 2023, 2024, 2025 and 2026."}],"balance_after":62499,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":31249},"source":{"system":"sec-edgar","filing":"0001493152-24-005942","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315224005942/ownership.xml","form_type":"4"}},{"id":1650324,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2024-02-13T02:27:33.000Z","date":"2024-02-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":12806,"price":1.08,"value":13830.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 31,249 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date hereof or shares that may be acquired upon the exercise of certain stock options."}],"balance_after":144842,"source":{"system":"sec-edgar","filing":"0001493152-24-005942","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315224005942/ownership.xml","form_type":"4"}},{"id":1650323,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2024-02-13T02:27:33.000Z","date":"2024-02-11","kind":"exercise","planned":false,"acquired":true,"shares":31249,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on February 11, 2022. RSUs convert into common shares on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on February 11, 2022. RSUs convert into common shares on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date hereof or shares that may be acquired upon the exercise of certain stock options."}],"balance_after":157648,"source":{"system":"sec-edgar","filing":"0001493152-24-005942","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315224005942/ownership.xml","form_type":"4"}},{"id":1959832,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-03-11T00:03:44.000Z","date":"2023-03-09","kind":"grant","acquired":true,"shares":1900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the options shall vest on March 9, 2024, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment."}],"balance_after":1900000,"derivative":{"exercise_price":1.46,"expiration_date":"2033-03-09","underlying":"Common Shares","underlying_shares":1900000},"source":{"system":"sec-edgar","filing":"0001493152-23-007306","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315223007306/ownership.xml","form_type":"4"}},{"id":2017881,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2023-02-14T21:15:52.000Z","date":"2023-02-11","kind":"exercise","acquired":false,"shares":31249,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Reporting Person was granted RSUs on February 11, 2022 that vested with respect to 25% of the shares subject to the award on February 11, 2023, and the balance will vest in 3 equal annual installments on each anniversary date thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Reporting Person was granted RSUs on February 11, 2022 that vested with respect to 25% of the shares subject to the award on February 11, 2023, and the balance will vest in 3 equal annual installments on each anniversary date thereafter."}],"balance_after":93748,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":31249},"source":{"system":"sec-edgar","filing":"0001493152-23-004898","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315223004898/ownership.xml","form_type":"4"}},{"id":2017880,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2023-02-14T21:15:52.000Z","date":"2023-02-11","kind":"tax_withholding","acquired":false,"shares":12744,"price":1.35,"value":17204.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 31,249 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this Report or shares that may be acquired upon the exercise of certain stock options."}],"balance_after":126399,"source":{"system":"sec-edgar","filing":"0001493152-23-004898","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315223004898/ownership.xml","form_type":"4"}},{"id":2017879,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2023-02-14T21:15:52.000Z","date":"2023-02-11","kind":"exercise","acquired":true,"shares":31249,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on February 11, 2022. RSUs convert into common shares on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on February 11, 2022. RSUs convert into common shares on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this Report or shares that may be acquired upon the exercise of certain stock options."}],"balance_after":139143,"source":{"system":"sec-edgar","filing":"0001493152-23-004898","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315223004898/ownership.xml","form_type":"4"}},{"id":2218945,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-06-30T21:57:05.000Z","date":"2022-06-30","kind":"exercise","acquired":false,"shares":15450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted RSUs on September 17, 2018, that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The reporting person was granted RSUs on September 17, 2018, that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":15450},"source":{"system":"sec-edgar","filing":"0001493152-22-018271","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315222018271/ownership.xml","form_type":"4"}},{"id":2218944,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2022-06-30T21:57:05.000Z","date":"2022-06-30","kind":"tax_withholding","acquired":false,"shares":5343,"price":1.58,"value":8441.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 15,450 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this report or shares that may be acquired upon the exercise of stock options outstanding as of the date of this report."}],"balance_after":107894,"source":{"system":"sec-edgar","filing":"0001493152-22-018271","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315222018271/ownership.xml","form_type":"4"}},{"id":2218943,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2022-06-30T21:57:05.000Z","date":"2022-06-30","kind":"exercise","acquired":true,"shares":15450,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares earned by the reporting person as a result of the vesting of a portion of restricted stock units (\"RSUs\") granted to the reporting person on September 17, 2018. RSUs convert into common shares on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares earned by the reporting person as a result of the vesting of a portion of restricted stock units (\"RSUs\") granted to the reporting person on September 17, 2018. RSUs convert into common shares on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this report or shares that may be acquired upon the exercise of stock options outstanding as of the date of this report."}],"balance_after":113237,"source":{"system":"sec-edgar","filing":"0001493152-22-018271","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315222018271/ownership.xml","form_type":"4"}},{"id":2309747,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-04-04T20:05:36.000Z","date":"2022-03-31","kind":"exercise","acquired":false,"shares":15450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The reporting person was granted RSUs on September 17, 2018, that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The reporting person was granted RSUs on September 17, 2018, that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter."}],"balance_after":15450,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":15450},"source":{"system":"sec-edgar","filing":"0001493152-22-009000","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315222009000/ownership.xml","form_type":"4"}},{"id":2309746,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2022-04-04T20:05:36.000Z","date":"2022-03-31","kind":"purchase","acquired":true,"shares":6400,"price":1.53,"value":9792.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average. The shares were purchased in multiple transactions at prices ranging from not less than $1.52 to not more than $1.54. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this report or shares that may be acquired upon the exercise of stock options outstanding as of the date of this report."}],"balance_after":97787,"source":{"system":"sec-edgar","filing":"0001493152-22-009000","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315222009000/ownership.xml","form_type":"4"}},{"id":2309745,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2022-04-04T20:05:36.000Z","date":"2022-03-31","kind":"tax_withholding","acquired":false,"shares":5343,"price":1.54,"value":8228.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this report or shares that may be acquired upon the exercise of stock options outstanding as of the date of this report."}],"balance_after":91387,"source":{"system":"sec-edgar","filing":"0001493152-22-009000","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315222009000/ownership.xml","form_type":"4"}},{"id":2309744,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2022-04-04T20:05:36.000Z","date":"2022-03-31","kind":"exercise","acquired":true,"shares":15450,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares earned by the reporting person as a result of the vesting of a portion of restricted stock units (\"RSUs\") granted to the reporting person on September 17, 2018. RSUs convert into common shares on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares earned by the reporting person as a result of the vesting of a portion of restricted stock units (\"RSUs\") granted to the reporting person on September 17, 2018. RSUs convert into common shares on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this report or shares that may be acquired upon the exercise of stock options outstanding as of the date of this report."}],"balance_after":96730,"source":{"system":"sec-edgar","filing":"0001493152-22-009000","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315222009000/ownership.xml","form_type":"4"}},{"id":2317205,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2022-03-28T23:22:18.000Z","date":"2022-03-25","kind":"purchase","acquired":true,"shares":5250,"price":1.38,"value":7245.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average. The shares were purchased in multiple transactions at prices ranging from not less than $1.3795 to not more than $1.3800. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range."}],"balance_after":81280,"source":{"system":"sec-edgar","filing":"0001493152-22-007925","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315222007925/ownership.xml","form_type":"4"}},{"id":2338646,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-03-12T01:45:59.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Grant of restricted stock units under Lineage's 2021 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one Common Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the shares will vest on or prior to March 9, 2023, and the second and third anniversaries of such date, upon the achievement of certain per share performance targets, calculated based on the trailing 20 trading day volume weighted average price of the Company's common stock as of the date of determination."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third of the shares will vest on or prior to March 9, 2023, and the second and third anniversaries of such date, upon the achievement of certain per share performance targets, calculated based on the trailing 20 trading day volume weighted average price of the Company's common stock as of the date of determination."}],"balance_after":300000,"derivative":{"underlying":"Common Shares","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001493152-22-006699","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315222006699/ownership.xml","form_type":"4"}},{"id":2338645,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-03-12T01:45:59.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":1250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the options shall vest on March 10, 2023, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment."}],"balance_after":1250000,"derivative":{"exercise_price":1.4,"expiration_date":"2032-03-10","underlying":"Common Shares","underlying_shares":1250000},"source":{"system":"sec-edgar","filing":"0001493152-22-006699","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315222006699/ownership.xml","form_type":"4"}},{"id":2395597,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-02-16T00:38:01.000Z","date":"2022-02-11","kind":"grant","acquired":true,"shares":124997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Grant of restricted stock units under Lineage's 2021 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one Common Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to continuous service, vests in four equal annual installments beginning on February 11, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to continuous service, vests in four equal annual installments beginning on February 11, 2023."}],"balance_after":124997,"derivative":{"underlying":"Common Shares","underlying_shares":124997},"source":{"system":"sec-edgar","filing":"0001493152-22-004714","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315222004714/ownership.xml","form_type":"4"}},{"id":2455164,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-01-03T21:25:31.000Z","date":"2021-12-31","kind":"exercise","acquired":false,"shares":15450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted RSUs on September 17, 2018, that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The reporting person was granted RSUs on September 17, 2018, that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter."}],"balance_after":30900,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":15450},"source":{"system":"sec-edgar","filing":"0001493152-22-000116","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315222000116/ownership.xml","form_type":"4"}},{"id":2455163,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2022-01-03T21:25:31.000Z","date":"2021-12-31","kind":"tax_withholding","acquired":false,"shares":5343,"price":2.45,"value":13090.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 15,450 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include common shares of the issuer that may be acquired upon settlement of RSUs that have not vested as of the date of this filing or upon the exercise of stock options outstanding as of the date of this filing."}],"balance_after":76030,"source":{"system":"sec-edgar","filing":"0001493152-22-000116","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315222000116/ownership.xml","form_type":"4"}},{"id":2455162,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2022-01-03T21:25:31.000Z","date":"2021-12-31","kind":"exercise","acquired":true,"shares":15450,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares earned by the reporting person as a result of the vesting of a portion of restricted stock units (\"RSUs\") granted to the reporting person on September 17, 2018. Upon settlement, RSUs convert into common shares of the issuer on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares earned by the reporting person as a result of the vesting of a portion of restricted stock units (\"RSUs\") granted to the reporting person on September 17, 2018. Upon settlement, RSUs convert into common shares of the issuer on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include common shares of the issuer that may be acquired upon settlement of RSUs that have not vested as of the date of this filing or upon the exercise of stock options outstanding as of the date of this filing."}],"balance_after":81373,"source":{"system":"sec-edgar","filing":"0001493152-22-000116","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315222000116/ownership.xml","form_type":"4"}},{"id":2544956,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2021-10-12T20:27:39.000Z","date":"2021-09-30","kind":"exercise","acquired":false,"shares":15450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted RSUs on September 17, 2018, that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The reporting person was granted RSUs on September 17, 2018, that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter."}],"balance_after":46350,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":15450},"source":{"system":"sec-edgar","filing":"0001493152-21-025197","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221025197/ownership.xml","form_type":"4"}},{"id":2544955,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2021-10-12T20:27:39.000Z","date":"2021-09-30","kind":"tax_withholding","acquired":false,"shares":5343,"price":2.52,"value":13464.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 15,450 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include common shares of the issuer that may be acquired upon settlement of RSUs that have not vested as of the date of this filing or upon the exercise of stock options outstanding as of the date of this filing."}],"balance_after":65923,"source":{"system":"sec-edgar","filing":"0001493152-21-025197","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221025197/ownership.xml","form_type":"4"}},{"id":2544954,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2021-10-12T20:27:39.000Z","date":"2021-09-30","kind":"exercise","acquired":true,"shares":15450,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares earned by the reporting person as a result of the vesting of a portion of restricted stock units (\"RSUs\") granted to the reporting person on September 17, 2018. Upon settlement, RSUs convert into common shares of the issuer on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares earned by the reporting person as a result of the vesting of a portion of restricted stock units (\"RSUs\") granted to the reporting person on September 17, 2018. Upon settlement, RSUs convert into common shares of the issuer on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include common shares of the issuer that may be acquired upon settlement of RSUs that have not vested as of the date of this filing or upon the exercise of stock options outstanding as of the date of this filing."}],"balance_after":71266,"source":{"system":"sec-edgar","filing":"0001493152-21-025197","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221025197/ownership.xml","form_type":"4"}},{"id":2650850,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2021-06-30T22:42:32.000Z","date":"2021-06-30","kind":"exercise","acquired":false,"shares":15450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The reporting person was granted RSUs on September 17, 2018, that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The reporting person was granted RSUs on September 17, 2018, that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter."}],"balance_after":61800,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":15450},"source":{"system":"sec-edgar","filing":"0001493152-21-015778","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221015778/ownership.xml","form_type":"4"}},{"id":2650849,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-06-30T22:42:32.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The reporting person was granted options on March 17, 2020, with an exercise price of $0.6919 per share to purchase up to 1,233,300 shares. One quarter of the options vested and became exercisable on March 17, 2021, the first anniversary of the grant date, and the balance vest in 36 monthly installments thereafter upon completion of each month of the reporting person's continuous employment."}],"balance_after":933300,"derivative":{"exercise_price":0.6919,"expiration_date":"2030-03-17","underlying":"Common Shares","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001493152-21-015778","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221015778/ownership.xml","form_type":"4"}},{"id":2650848,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2021-06-30T22:42:32.000Z","date":"2021-06-30","kind":"tax_withholding","acquired":false,"shares":5343,"price":2.85,"value":15227.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 15,450 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include restricted stock units (\"RSUs\") that may be settled in shares of the issuer's common stock that have not vested as of the date of this report or shares that may be acquired upon the exercise of stock options outstanding as of the date of this report."}],"balance_after":55816,"source":{"system":"sec-edgar","filing":"0001493152-21-015778","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221015778/ownership.xml","form_type":"4"}},{"id":2650847,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2021-06-30T22:42:32.000Z","date":"2021-06-30","kind":"exercise","acquired":true,"shares":15450,"price":2.85,"value":44032.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares earned by the reporting person as a result of the vesting of a portion of RSUs granted to the reporting person on September 17, 2018. RSUs convert into common shares on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include restricted stock units (\"RSUs\") that may be settled in shares of the issuer's common stock that have not vested as of the date of this report or shares that may be acquired upon the exercise of stock options outstanding as of the date of this report."}],"balance_after":61159,"source":{"system":"sec-edgar","filing":"0001493152-21-015778","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221015778/ownership.xml","form_type":"4"}},{"id":2650846,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2021-06-30T22:42:32.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":450000,"price":2.87,"value":1291500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average. These shares were sold in multiple transactions at prices ranging from not less than $2.81 to not more than $2.93. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include restricted stock units (\"RSUs\") that may be settled in shares of the issuer's common stock that have not vested as of the date of this report or shares that may be acquired upon the exercise of stock options outstanding as of the date of this report."}],"balance_after":45709,"source":{"system":"sec-edgar","filing":"0001493152-21-015778","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221015778/ownership.xml","form_type":"4"}},{"id":2650845,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2021-06-30T22:42:32.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":300000,"price":0.6919,"value":207570.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include restricted stock units (\"RSUs\") that may be settled in shares of the issuer's common stock that have not vested as of the date of this report or shares that may be acquired upon the exercise of stock options outstanding as of the date of this report."}],"balance_after":495709,"source":{"system":"sec-edgar","filing":"0001493152-21-015778","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221015778/ownership.xml","form_type":"4"}},{"id":2765268,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2021-04-02T00:00:12.000Z","date":"2021-03-31","kind":"exercise","acquired":false,"shares":15450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Reporting Person was granted RSUs on September 17, 2018 that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Reporting Person was granted RSUs on September 17, 2018 that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter."}],"balance_after":77250,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":15450},"source":{"system":"sec-edgar","filing":"0001493152-21-007794","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221007794/ownership.xml","form_type":"4"}},{"id":2765267,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2021-04-02T00:00:12.000Z","date":"2021-03-31","kind":"tax_withholding","acquired":false,"shares":5343,"price":2.35,"value":12556.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 15,450 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this Report or shares that may be acquired upon the exercise of certain stock options."}],"balance_after":195709,"source":{"system":"sec-edgar","filing":"0001493152-21-007794","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221007794/ownership.xml","form_type":"4"}},{"id":2765266,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2021-04-02T00:00:12.000Z","date":"2021-03-31","kind":"exercise","acquired":true,"shares":15450,"price":2.35,"value":36307.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on September 17, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this Report or shares that may be acquired upon the exercise of certain stock options."}],"balance_after":201052,"source":{"system":"sec-edgar","filing":"0001493152-21-007794","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221007794/ownership.xml","form_type":"4"}},{"id":2784204,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-03-17T21:00:46.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":1165100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the options shall vest on March 15, 2022 and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment."}],"balance_after":1165100,"derivative":{"exercise_price":2.43,"expiration_date":"2031-03-15","underlying":"Common Shares","underlying_shares":1165100},"source":{"system":"sec-edgar","filing":"0001493152-21-006274","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221006274/ownership.xml","form_type":"4"}},{"id":2928179,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2020-12-31T22:00:08.000Z","date":"2020-12-31","kind":"exercise","acquired":false,"shares":15450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Reporting Person was granted RSUs on September 17, 2018 that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Reporting Person was granted RSUs on September 17, 2018 that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter."}],"balance_after":92700,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":15450},"source":{"system":"sec-edgar","filing":"0001493152-20-024692","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315220024692/ownership.xml","form_type":"4"}},{"id":2928178,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2020-12-31T22:00:08.000Z","date":"2020-12-31","kind":"tax_withholding","acquired":false,"shares":5343,"price":1.76,"value":9403.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 15,450 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this Report or shares that may be acquired upon the exercise of certain stock options."}],"balance_after":185602,"source":{"system":"sec-edgar","filing":"0001493152-20-024692","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315220024692/ownership.xml","form_type":"4"}},{"id":2928177,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2020-12-31T22:00:08.000Z","date":"2020-12-31","kind":"exercise","acquired":true,"shares":15450,"price":1.76,"value":27192.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on September 17, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this Report or shares that may be acquired upon the exercise of certain stock options."}],"balance_after":190945,"source":{"system":"sec-edgar","filing":"0001493152-20-024692","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315220024692/ownership.xml","form_type":"4"}},{"id":3020297,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2020-09-30T21:00:08.000Z","date":"2020-09-30","kind":"exercise","acquired":false,"shares":15450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Reporting Person was granted RSUs on September 17, 2018 that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Reporting Person was granted RSUs on September 17, 2018 that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter."}],"balance_after":108150,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":15450},"source":{"system":"sec-edgar","filing":"0001493152-20-018634","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315220018634/ownership.xml","form_type":"4"}},{"id":3020296,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2020-09-30T21:00:08.000Z","date":"2020-09-30","kind":"tax_withholding","acquired":false,"shares":5343,"price":0.9366,"value":5004.2538,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 15,450 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this Report or shares that may be acquired upon the exercise of certain stock options."}],"balance_after":175495,"source":{"system":"sec-edgar","filing":"0001493152-20-018634","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315220018634/ownership.xml","form_type":"4"}},{"id":3020295,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2020-09-30T21:00:08.000Z","date":"2020-09-30","kind":"exercise","acquired":true,"shares":15450,"price":0.9366,"value":14470.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on September 17, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this Report or shares that may be acquired upon the exercise of certain stock options."}],"balance_after":180838,"source":{"system":"sec-edgar","filing":"0001493152-20-018634","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315220018634/ownership.xml","form_type":"4"}},{"id":3093742,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2020-07-02T21:05:48.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":15450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Reporting Person was granted RSUs on September 17, 2018 that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Reporting Person was granted RSUs on September 17, 2018 that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter."}],"balance_after":123600,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":15450},"source":{"system":"sec-edgar","filing":"0001493152-20-012542","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315220012542/ownership.xml","form_type":"4"}},{"id":3093741,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2020-07-02T21:05:48.000Z","date":"2020-06-30","kind":"tax_withholding","acquired":false,"shares":5343,"price":0.87,"value":4648.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 15,450 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this Report or shares that may be acquired upon the exercise of certain stock options."}],"balance_after":165388,"source":{"system":"sec-edgar","filing":"0001493152-20-012542","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315220012542/ownership.xml","form_type":"4"}},{"id":3093740,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2020-07-02T21:05:48.000Z","date":"2020-06-30","kind":"exercise","acquired":true,"shares":15450,"price":0.87,"value":13441.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on September 17, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this Report or shares that may be acquired upon the exercise of certain stock options."}],"balance_after":170731,"source":{"system":"sec-edgar","filing":"0001493152-20-012542","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315220012542/ownership.xml","form_type":"4"}},{"id":3191572,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2020-04-01T00:00:19.000Z","date":"2020-03-31","kind":"exercise","acquired":false,"shares":15450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Reporting Person was granted RSUs on September 17, 2018 that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Reporting Person was granted RSUs on September 17, 2018 that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter."}],"balance_after":139050,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":15450},"source":{"system":"sec-edgar","filing":"0001493152-20-005529","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315220005529/ownership.xml","form_type":"4"}},{"id":3191571,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2020-04-01T00:00:19.000Z","date":"2020-03-31","kind":"tax_withholding","acquired":false,"shares":5343,"price":0.8281,"value":4424.5383,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 15,450 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this Report or shares that may be acquired upon the exercise of certain stock options."}],"balance_after":155281,"source":{"system":"sec-edgar","filing":"0001493152-20-005529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315220005529/ownership.xml","form_type":"4"}},{"id":3191570,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2020-04-01T00:00:19.000Z","date":"2020-03-31","kind":"exercise","acquired":true,"shares":15450,"price":0.8281,"value":12794.145,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on September 17, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this Report or shares that may be acquired upon the exercise of certain stock options."}],"balance_after":160624,"source":{"system":"sec-edgar","filing":"0001493152-20-005529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315220005529/ownership.xml","form_type":"4"}},{"id":3201266,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-03-19T21:00:12.000Z","date":"2020-03-17","kind":"grant","acquired":true,"shares":1233300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the options shall vest on March 17, 2021 and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment."}],"balance_after":1233300,"derivative":{"exercise_price":0.6919,"expiration_date":"2030-03-17","underlying":"Common Shares","underlying_shares":1233300},"source":{"system":"sec-edgar","filing":"0001493152-20-004349","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315220004349/ownership.xml","form_type":"4"}},{"id":3329310,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2019-12-31T22:00:26.000Z","date":"2019-12-31","kind":"exercise","acquired":false,"shares":15450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Reporting Person was granted RSUs on September 17, 2018 that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Reporting Person was granted RSUs on September 17, 2018 that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter."}],"balance_after":154500,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":15450},"source":{"system":"sec-edgar","filing":"0001493152-19-019942","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315219019942/ownership.xml","form_type":"4"}},{"id":3329309,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2019-12-31T22:00:26.000Z","date":"2019-12-31","kind":"tax_withholding","acquired":false,"shares":5343,"price":0.89,"value":4755.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 15,450 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this Report or shares that may be acquired upon the exercise of certain stock options."}],"balance_after":145174,"source":{"system":"sec-edgar","filing":"0001493152-19-019942","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315219019942/ownership.xml","form_type":"4"}},{"id":3329308,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2019-12-31T22:00:26.000Z","date":"2019-12-31","kind":"exercise","acquired":true,"shares":15450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on September 17, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this Report or shares that may be acquired upon the exercise of certain stock options."}],"balance_after":150517,"source":{"system":"sec-edgar","filing":"0001493152-19-019942","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315219019942/ownership.xml","form_type":"4"}},{"id":3403725,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2019-10-01T21:00:41.000Z","date":"2019-09-30","kind":"exercise","acquired":false,"shares":15450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Reporting Person was granted RSUs on September 17, 2018 that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Reporting Person was granted RSUs on September 17, 2018 that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter."}],"balance_after":169950,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":15450},"source":{"system":"sec-edgar","filing":"0001493152-19-014834","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315219014834/ownership.xml","form_type":"4"}},{"id":3403724,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2019-10-01T21:00:41.000Z","date":"2019-09-30","kind":"tax_withholding","acquired":false,"shares":5343,"price":0.98,"value":5236.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 15,450 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this Report or shares that may be acquired upon the exercise of certain stock options."}],"balance_after":135067,"source":{"system":"sec-edgar","filing":"0001493152-19-014834","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315219014834/ownership.xml","form_type":"4"}},{"id":3403723,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2019-10-01T21:00:41.000Z","date":"2019-09-30","kind":"exercise","acquired":true,"shares":15450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on September 17, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this Report or shares that may be acquired upon the exercise of certain stock options."}],"balance_after":140410,"source":{"system":"sec-edgar","filing":"0001493152-19-014834","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315219014834/ownership.xml","form_type":"4"}},{"id":3410276,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2019-09-19T21:00:12.000Z","date":"2019-09-17","kind":"exercise","acquired":false,"shares":61800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Reporting Person was granted 200,000 RSUs on September 17, 2018 that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter. See note 1 for certain information regarding an adjustment to the number of shares subject to these RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Reporting Person was granted 200,000 RSUs on September 17, 2018 that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter. See note 1 for certain information regarding an adjustment to the number of shares subject to these RSUs."}],"balance_after":185400,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":61800},"source":{"system":"sec-edgar","filing":"0001493152-19-014321","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315219014321/ownership.xml","form_type":"4"}},{"id":3410275,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2019-09-19T21:00:12.000Z","date":"2019-09-17","kind":"tax_withholding","acquired":false,"shares":21371,"price":1,"value":21371.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 61,800 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this Report or shares that may be acquired upon the exercise of certain stock options."}],"balance_after":124960,"source":{"system":"sec-edgar","filing":"0001493152-19-014321","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315219014321/ownership.xml","form_type":"4"}},{"id":3410274,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2019-09-19T21:00:12.000Z","date":"2019-09-17","kind":"exercise","acquired":true,"shares":61800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on September 17, 2018. In connection with the issuer's distribution of shares of common stock of AgeX, Inc. it owned to all its shareholders, the number of shares subject to these RSUs was adjusted from 200,000 to 247,200 to maintain the intrinsic value of the award. See the issuer's proxy statement as filed with the Securities and Exchange Commission on June 14, 2019 for additional information regarding such distribution."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this Report or shares that may be acquired upon the exercise of certain stock options."}],"balance_after":146331,"source":{"system":"sec-edgar","filing":"0001493152-19-014321","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315219014321/ownership.xml","form_type":"4"}},{"id":3438000,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2019-08-15T12:39:07.000Z","date":"2019-08-13","kind":"purchase","acquired":true,"shares":10000,"price":1.01,"value":10100.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of common shares beneficially owned by the reporting person includes 15,411 additional common shares that were issued to the reporting person to maintain the intrinsic value of restricted stock unit awards immediately prior to the issuer's distribution of common stock of AgeX, Inc. See the issuer's proxy statement as filed with the Securities and Exchange Commission on June 14, 2019 for additional information."}],"balance_after":84531,"source":{"system":"sec-edgar","filing":"0001209191-19-046029","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919119046029/doc4.xml","form_type":"4"}},{"id":3710987,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2019-01-04T01:35:57.000Z","date":"2019-01-01","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vested on January 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vested on January 1, 2019."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-19-001577","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919119001577/doc4.xml","form_type":"4"}},{"id":3710986,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2019-01-04T01:35:57.000Z","date":"2019-01-01","kind":"tax_withholding","acquired":false,"shares":40880,"price":0.913,"value":37323.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 100,000 Restricted Stock Units, the grant of which\nwas previously reported on a Form 8-K."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":59120,"source":{"system":"sec-edgar","filing":"0001209191-19-001577","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919119001577/doc4.xml","form_type":"4"}},{"id":3710985,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares, no par value","published_at":"2019-01-04T01:35:57.000Z","date":"2019-01-01","kind":"exercise","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares earned by the Reporting Person as a result of the vesting of Restrictive Stock Units (\"RSUs\") granted to the Reporting Person on September 17, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001209191-19-001577","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919119001577/doc4.xml","form_type":"4"}},{"id":3812088,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2018-09-20T01:07:45.000Z","date":"2018-09-17","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Grant of restricted stock units under the BioTime 2012 Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one Common Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to continuous service, the restricted stock units shall vest fully on January 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Subject to continuous service, the restricted stock units shall vest fully on January 1, 2019."}],"balance_after":100000,"derivative":{"underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-18-051722","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118051722/doc4.xml","form_type":"4"}},{"id":3812087,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2018-09-20T01:07:45.000Z","date":"2018-09-17","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Grant of restricted stock units under the BioTime 2012 Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one Common Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to continuous service, one quarter of the restricted stock units shall vest on September 17, 2019 and the balance shall vest in twelve equal quarterly installments at the end of each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to continuous service, one quarter of the restricted stock units shall vest on September 17, 2019 and the balance shall vest in twelve equal quarterly installments at the end of each quarter thereafter."}],"balance_after":200000,"derivative":{"underlying":"Common Shares","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-18-051722","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118051722/doc4.xml","form_type":"4"}},{"id":3812086,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Qualified Option to Purchase Common Shares","published_at":"2018-09-20T01:07:45.000Z","date":"2018-09-17","kind":"grant","acquired":true,"shares":1500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Inducement option grant made outside the BioTime 2012 Equity incentive Plan, as amended, in reliance on the employment inducement exemption to shareholder approval provided under the New York Stock Exchange's Listed Company Manual Rule 303A.08."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to continuous service, one quarter of the options shall vest on September 17, 2019, and the balance of the options shall vest in 36 equal monthly installments at the end of each one-month period thereafter."}],"balance_after":1500000,"derivative":{"exercise_price":2.31,"expiration_date":"2028-09-16","underlying":"Common Shares","underlying_shares":1500000},"source":{"system":"sec-edgar","filing":"0001209191-18-051722","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118051722/doc4.xml","form_type":"4"}},{"id":3990210,"issuer":{"id":124649,"kind":"organization","name":"Artemis Therapeutics, Inc.","symbol":"ATMS"},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-19T20:17:39.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":48528,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":48528,"derivative":{"exercise_price":1.3,"exercise_date":"2018-03-15","expiration_date":"2028-03-15","underlying":"Common Stock","underlying_shares":48528},"source":{"system":"sec-edgar","filing":"0001178913-18-000896","document":"zka1821374.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062128/000117891318000896/zka1821374.xml","form_type":"4"}},{"id":4180775,"issuer":{"id":124649,"kind":"organization","name":"Artemis Therapeutics, Inc.","symbol":"ATMS"},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant","published_at":"2017-10-25T12:12:06.000Z","date":"2017-10-23","kind":"purchase","acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities consist of units purchased by the reporting person for $1.00 per unit."}],"balance_after":12500,"derivative":{"exercise_price":2,"exercise_date":"2017-10-23","expiration_date":"2022-10-23","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001178913-17-002876","document":"zk1720650.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062128/000117891317002876/zk1720650.xml","form_type":"4"}},{"id":4180774,"issuer":{"id":124649,"kind":"organization","name":"Artemis Therapeutics, Inc.","symbol":"ATMS"},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-10-25T12:12:06.000Z","date":"2017-10-23","kind":"purchase","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities consist of units purchased by the reporting person for $1.00 per unit."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001178913-17-002876","document":"zk1720650.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062128/000117891317002876/zk1720650.xml","form_type":"4"}},{"id":4218268,"issuer":{"id":124649,"kind":"organization","name":"Artemis Therapeutics, Inc.","symbol":"ATMS"},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-09-05T20:37:47.000Z","date":"2017-08-09","kind":"grant","acquired":true,"shares":242640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, representing a right to purchase 242,640 shares of the Issuer's common stock at an exercise price of $1.30 per share, vests ratably over a 48 month period commencing on the first day of the month following the date of issuance."}],"balance_after":242640,"derivative":{"exercise_price":1.3,"expiration_date":"2027-08-09","underlying":"Common Stock","underlying_shares":242640},"source":{"system":"sec-edgar","filing":"0001178913-17-002618","document":"zk1720526.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062128/000117891317002618/zk1720526.xml","form_type":"4"}},{"id":4484219,"issuer":{"id":4900,"kind":"organization","name":"Savara Inc","symbol":"SVRA"},"owners":[{"id":61382,"kind":"person","name":"Culley Brian M","position":1,"cik":"0001310683","reported_name":"Culley Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Restricted Stock Units","published_at":"2017-01-23T22:18:35.000Z","date":"2017-01-20","kind":"grant","acquired":true,"shares":2368194,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017)."}],"balance_after":2368194,"derivative":{"underlying":"Common Stock","underlying_shares":2368194},"source":{"system":"sec-edgar","filing":"0001209191-17-005130","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160308/000120919117005130/doc4.xml","form_type":"4"}}]}